ArticleFrontiers in oncology2022

Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with cystic brain metastases: A case report and literature review.

Zhaohui ChuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.